HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful combination chemotherapy (vincristine, procarbazine, etoposide, and prednisolone) in the treatment of inoperable, radioresistant low grade astrocytoma: a case report.

Abstract
A case of successful combination chemotherapy using vincristine, procarbazine, VP-16 and prednisolone to treat an inoperable low grade astrocytoma is presented. This patient, whose tumor was also resistant to radiotherapy, had well controlled symptoms after the initiation of chemotherapy. A brain CT scan demonstrated disappearance of the tumor mass after eight courses of a combination chemotherapy regimen. She is at present symptom-free 80 months after diagnosis. This result suggests that combination chemotherapy may offer treatment modalities for low grade astrocytoma.
AuthorsP Maipang MVasiknanonte, S Janjindamai SHirunpat
JournalJournal of the Medical Association of Thailand = Chotmaihet thangphaet (J Med Assoc Thai) Vol. 83 Issue 12 Pg. 1525-9 (Dec 2000) ISSN: 0125-2208 [Print] Thailand
PMID11253894 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Procarbazine
  • Vincristine
  • Etoposide
  • Prednisolone
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Astrocytoma (drug therapy, radiotherapy)
  • Brain Neoplasms (drug therapy, radiotherapy)
  • Child
  • Etoposide (administration & dosage)
  • Female
  • Humans
  • Prednisolone (administration & dosage)
  • Procarbazine (administration & dosage)
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: